BioAge Labs, Inc. Common Stock

BIOANASDAQUSD
15.70 USD
1.32 (7.76%)AT CLOSE (11:59 AM EDT)
16.42
0.72 (4.61%)
POST MARKET (AS OF 07:52 PM EDT)
Post Market
AS OF 07:52 PM EDT
16.42
0.72 (4.61%)
🔴Market: CLOSED
Open?$16.87
High?$17.16
Low?$15.68
Prev. Close?$17.02
Volume?376.3K
Avg. Volume?394.0K
VWAP?$16.19
Rel. Volume?0.96x
Bid / Ask
Bid?$13.33 × 100
Ask?$19.17 × 100
Spread?$5.84
Midpoint?$16.25
Valuation & Ratios
Market Cap?697.9M
Shares Out?44.5M
Float?18.5M
Float %?51.6%
P/E Ratio?N/A
P/B Ratio?1.84
EPS?-$2.02
Dividend?0.00%
Ex-Dividend?N/A

Shares of BioAge Labs, Inc. Common Stock (BIOA) are trading at $15.70. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, BIOA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Employees
62
Market Cap
697.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-09-26
Address
5885 HOLLIS STREET
EMERYVILLE, CA 94608
Phone: 510-806-1445
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
57
Short Sent.?
65
Piotroski F-Score?0/9Weak
Altman Z-Score?21.66Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.23%Elevated
Short Interest?1.7M
Days to Cover?4.6
Free Float18.5M
Avg Daily Volume372.5K
Settlement Date2026-05-15
Financial Health
Current Ratio?24.76Strong
Quick Ratio?24.76Strong
Cash Ratio?15.28Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
79
1.84CHEAP
P/S?
Peers
100
S&P
3
67.65HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-4.5CHEAP
EV/Sales?
Peers
100
S&P
3
44.33HIGH
Returns & Efficiency
ROE?
S&P
7
-23.7%WEAK
ROA?
S&P
3
-22.6%WEAK
Cash Flow & Enterprise
FCF?$-88629000
Enterprise Value?$457.3M
Fundamentals ratios updated end of day